| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 843782-19-4 | LEU-PRO-ARG-LEU-LEU-his-thr-ASP-SER-ARG-MET-ALA-thr-ILE-ASP-PHE-PRO-LYS-LYS-ASP-PRO-thr-thr-SER-LEU- | H-LEU-PRO-ARG-LEU-LEU-his-thr-ASP-SER-ARG-MET-ALA-thr-ILE-ASP-PHE-PRO-LYS-LYS-ASP-PRO-thr-thr-SER-LE; H-LEU-PRO-ARG-LEU-LEU-his-thr-ASP-SER-ARG-MET-ALA-thr-ILE-ASP-PHE-PRO-LYS-LYS-ASP-PRO-thr-thr-SER-LEU-GLY-ARG-PRO-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2; NEUROMEDIN S (RAT); NMS (RAT) | 无 | C193H307N57O49S | 详情 | 供应商 |
| 383415-79-0 | TRP-TYR-LYS-his-VAL-ALA-SER-PRO-ARG-TYR-his-thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU | H-TRP-TYR-LYS-his-VAL-ALA-SER-PRO-ARG-TYR-his-thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH; NPW-23 (HUMAN); NEUROPEPTIDE W-23 (HUMAN); TRP-TYR-LYS-his-VAL-ALA-SER-PRO-ARG-TYR-his-thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU; H-TRP-TYR-LYS-his-VAL-ALA-SER-PRO-ARG-TYR-his-thr-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH | ![]() | C119H183N35O28S | 详情 | 供应商 |
| 112540-82-6 | ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA; ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA; ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-his-GLN-LEU-LEU-his-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-his-his-LEU-ILE-ALA-GLU-ILE-his-thr-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |